Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6827350 | Schizophrenia Research | 2011 | 7 Pages |
Abstract
Because TAT did not reduce total healthcare costs, it did not contribute to cost-minimization. Its benefits are therefore questionable. No other adherence intervention has included analysis of cost-effectiveness or cost-minimization.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
J. Gilden, A.B.P. Staring, M. van der Gaag, C.L. Mulder,